Standard InChI: InChI=1S/C34H42F3N5O8/c35-34(36,37)27-8-2-1-6-24(27)23-12-10-22(11-13-23)20-26-25(31(45)41-48)7-5-17-50-33(47)38-14-4-3-9-28(40-30(26)44)32(46)39-21-29(43)42-15-18-49-19-16-42/h1-2,6,8,10-13,25-26,28,48H,3-5,7,9,14-21H2,(H,38,47)(H,39,46)(H,40,44)(H,41,45)/t25-,26+,28-/m0/s1
Standard InChI Key: RWKJBOMUESGCBO-REUBFRLUSA-N
Associated Targets(Human)
Homo sapiens 32628 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase-1 7046 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase-2 6627 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 9 6779 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 3 3433 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 7 1073 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 8 1942 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 10 359 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 12 1130 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 13 4133 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 14 1592 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 15 49 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Matrix metalloproteinase 16 81 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
ADAM17 434 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 705.73
Molecular Weight (Monoisotopic): 705.2985
AlogP: 2.80
#Rotatable Bonds: 7
Polar Surface Area: 175.40
Molecular Species: NEUTRAL
HBA: 8
HBD: 5
#RO5 Violations: 1
HBA (Lipinski): 13
HBD (Lipinski): 5
#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.86
CX Basic pKa:
CX LogP: 2.04
CX LogD: 2.02
Aromatic Rings: 2
Heavy Atoms: 50
QED Weighted: 0.22
Np Likeness Score: -0.51
References
1.Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP.. (2001) Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release., 44 (21):[PMID:11585440][10.1021/jm0155502]
2.Xue CB, He X, Roderick J, Corbett RL, Duan JJ, Liu RQ, Covington MB, Newton RC, Trzaskos JM, Magolda RL, Wexler RR, Decicco CP.. (2003) Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification., 13 (24):[PMID:14643312][10.1016/j.bmcl.2003.09.056]
3.Georgiadis D, Yiotakis A.. (2008) Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge., 16 (19):[PMID:18790648][10.1016/j.bmc.2008.08.058]